Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

View the 50 largest pharmaceutical companies in the world listings here

Ipsen

Ipsen

Rank: 45

Paris, France
www.ipsen.com

2020 Revenues ($USD) : $3,062,268,000
2020 Revenues (foreign currencies) : €2,686,200,000
2020 R&D spend : $461,700,000
2020 Number of Employees : 5,700
Fiscal Year End : 12/31/2020
Key People : David Loew, CEO

Ipsen is a mid-size biopharmaceutical company focusing on transformative medicines in oncology, rare diseases and neuroscience. It markets more than 20 drugs in over 115 countries, with a direct commercial presence in more than 30 countries. Ipsen has located its R&D in major biotech and life sciences hubs, including Paris-Saclay in France; Oxford, U.K.; Cambridge, Mass.; and Shanghai. –CN

Ipsen

Interior of Cambridge facility. Image courtesy of Ipsen Biopharmaceuticals.

Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50